Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 1
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| W81XWH05C0157 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $6.98M | 2005-08-22 | 2013-07-31 | 541710 | — |
| SPE2DP25F2789 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $5.29M | 2025-01-28 | 2025-02-04 | 325412 | 8511147946!ADENOVIRUS TYPE 4 A |
| SPE2DP26F3586 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $3.95M | 2026-03-18 | 2026-03-25 | 325412 | 8511984334!ADENOVIRUS TYPE 4 A |
| SPE2DP26F2814 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $3.95M | 2026-02-17 | 2026-02-24 | 325412 | 8511918533!ADENOVIRUS TYPE 4 A |
| SPE2DP26F1649 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $3.95M | 2026-01-13 | 2026-01-27 | 325412 | 8511856699!ADENOVIRUS TYPE 4 A |
| SPE2DP25F0856 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $3.18M | 2024-11-14 | 2024-11-19 | 325412 | 8511009796!ADENOVIRUS TYPE 4 A |
| SPE2DP24F1238 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $2.44M | 2023-12-14 | 2023-12-19 | 325412 | 8510325537!ADENOVIRUS TYPE 4 A |
| SPE2DP26F0979 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.98M | 2025-12-01 | 2025-12-09 | 325412 | 8511784063!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3911 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.59M | 2024-04-09 | 2024-04-30 | 325412 | 8510559015!ADENOVIRUS TYPE 4 A |
| SPE2DP24F1236 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.53M | 2023-12-14 | 2023-12-19 | 325412 | 8510325475!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6263 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.43M | 2024-07-19 | 2024-07-30 | 325412 | 8510766857!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5483 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.43M | 2024-06-13 | 2024-06-25 | 325412 | 8510688482!ADENOVIRUS TYPE 4 A |
| SPE2DP24F4773 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.43M | 2024-05-15 | 2024-05-21 | 325412 | 8510634433!ADENOVIRUS TYPE 4 A |
| SPE2DP20F7224 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.36M | 2020-09-21 | 2020-09-29 | 325412 | 8507666472!ADENOVIRUS TYPE 4 A |
| SPE2DP20F7220 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.36M | 2020-09-21 | 2020-09-29 | 325412 | 8507666398!ADENOVIRUS TYPE 4 A |
| SPE2DP26F0980 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.32M | 2025-12-01 | 2025-12-09 | 325412 | 8511784064!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7996 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.27M | 2024-09-18 | 2024-09-24 | 325412 | 8510902080!ADENOVIRUS TYPE 4 A |
| SPE2DP24F1993 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.27M | 2024-01-25 | 2024-01-30 | 325412 | 8510401601!ADENOVIRUS TYPE 4 A |
| SPE2DP20F7221 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.22M | 2020-09-21 | 2020-09-29 | 325412 | 8507666399!ADENOVIRUS TYPE 4 A |
| SPE2DP20F2430 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.22M | 2020-02-07 | 2020-02-11 | 325412 | 8507153551!ADENOVIRUS TYPE 4 A |
| SPE2DP25F055D | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.16M | 2025-08-12 | 2025-08-26 | 325412 | 8511565495!ADENOVIRUS TYPE 4 A |
| SPE2DP25F2792 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.16M | 2025-01-28 | 2025-02-04 | 325412 | 8511148052!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7165 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.11M | 2024-08-22 | 2024-08-27 | 325412 | 8510839749!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3172 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.11M | 2024-03-13 | 2024-03-26 | 325412 | 8510500489!ADENOVIRUS TYPE 4 A |
| SPE2DP20F2435 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $1.09M | 2020-02-07 | 2020-02-11 | 325412 | 8507153570!ADENOVIRUS TYPE 4 A |